在T切换的TCR特异性

Andrew Y Hu1, Cristina Puig-Saus2

  • 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at the University of California Los Angeles (UCLA), Los Angeles, CA, USA; Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine at the University of California Los Angeles (UCLA), Los Angeles, CA, USA.

Immunity
|December 11, 2024
PubMed
概括

研究人员从非自我反应的T细胞中设计了自我反应的T细胞受体 (TCR). 这一进展显示了开发针对自我抗原的T细胞免疫疗法的潜力.